Provided by Tiger Trade Technology Pte. Ltd.

VanEck Biotech ETF

231.17
+0.46970.20%
Post-market: 231.350.1766+0.08%19:30 EDT
Volume:3K
Turnover:791.94K
Market Cap:463.85M
PE:- -
High:231.68
Open:231.68
Low:231.17
Close:230.70
52wk High:244.35
52wk Low:160.91
Shares:2.01M
Float Shares:2.01M
Volume Ratio:0.42
T/O Rate:0.17%
Dividend:0.95
Dividend Rate:0.41%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Guardant Health (GH) and Neurocrine (NBIX)

TIPRANKS
·
Sep 08

Structure Therapeutics reports ACCG-2671, aleniglipron trial results

TIPRANKS
·
Sep 08

Political and General News Events from September 8

Reuters
·
Sep 08

Mirum Pharmaceuticals Names Rob Myers Chief Medical Officer Effective Sept. 21, 2026

Reuters
·
Sep 08

【US Pre-Market】Middle East Energy Risks Escalate, Brent Crude Nears $100, Oil and Gas Stocks Rise; Novartis Plunges 13%

TradingKey
·
Sep 08

Intel, Amgen, Novartis, Bloom Energy, and More Stocks That Explain Today's Market

Dow Jones
·
Sep 08

Beneath the Surface, the Next Market Leaders are Getting Ready to Break Out, Says Morgan Stanley

Dow Jones
·
Sep 08

Ionis Pharma Tumbles After Heart Drug Fails Late-Stage Trial

Reuters
·
Sep 08

Why Amgen Stock is Dropping After Swiss Rival's Trial Setback

Dow Jones
·
Sep 08

Amgen Falls After Novartis Trial Setback, BMO Downgrade

Reuters
·
Sep 08

Stocks to Watch: Amgen, Nike, Bloom Energy

Dow Jones
·
Sep 08

Amgen Shares Down 5.4% Premarket; Rival Novartis Cholesterol Drug Fails Late-Stage Study

THOMSON REUTERS
·
Sep 08

Why the Dow is Being Dragged Down by a Swiss Company's Bad News

Dow Jones
·
Sep 08

Gilead Sciences (GILD) Receives a Buy from Bernstein

TIPRANKS
·
Sep 08

Sino Biopharmaceutical Stock Slides 1.2% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 07

Novartis Cholesterol Setback Tests Hopes for Emerging Heart Disease Drugs

Reuters
·
Sep 07

Second Clinical Trial Blow in a Week for Novartis as Heart Drug Disappoints, Dragging Down Amgen Shares

Stock News
·
Sep 07

A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?

Dow Jones
·
Sep 06

Aclaris, EyePoint, Vertex, GitLab, NioCorp Trending With Analysts

TIPRANKS
·
Sep 05

Amgen EVP, CFO Thomas J.W. Dittrich Files Initial Beneficial Ownership Statement

Reuters
·
Sep 05